首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis
Authors:M. C. Patel  R. B. Patel  P. Ramanathan  N. Ramamoorthy  B. A. Krishna  S. M. Sharma
Affiliation:(1) Radiation Medicine Centre, Parel, 400 012 Bombay, India;(2) Bhabha Atomic Research Centre, Parel, 400 012 Bombay, India;(3) Tata Memorial Centre Annexe, Parel, 400 012 Bombay, India
Abstract:99mTc(V)-DMSA kits developed by the Radiopharmaceutical Division, Bhabha Atomic Research Centre, have been evaluated for potential use in scanning medullary carcinoma of the thyroid and its metastases. There were 15 patients with proved medullary carcinoma and 6 patients with other differentiated thyroid carcinoma. Amongst the 15 patients with medullary carcinoma, 12(80%) showed positive localisation either in the primary or one or more metastatic sites. None of the six patients with carcinoma other than medullary showed increased concentration of 99mTc (V)-DMSA. Of the 37 known metastatic sites in 15 patients with medullary carcinoma, 24 showed concentration of 99mTc (V)-DMSA (64.9%). In addition, 99mTc(V)-DMSA concentration was seen in 14 sites where no evidence of metastasis was revealed. The incidence of 99mTc (V)-DMSA concentration in soft tissue and bone metastasis was similar.Isopharm, Radiopharmaceutical Division, BARC, Bombay-400 705, India
Keywords:Medullary carcinoma  99mTc(V)-DMSA
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号